|
NUCKS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.22549999984167E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.83770000328209E-08 |
| Normal-vs-Stage2 |
3.62480000000165E-05 |
| Normal-vs-Stage3 |
1.829350E-01 |
| Normal-vs-Stage4 |
1.753360E-01 |
| Stage1-vs-Stage2 |
9.144400E-01 |
| Stage1-vs-Stage3 |
1.034380E-02 |
| Stage1-vs-Stage4 |
6.430200E-01 |
| Stage2-vs-Stage3 |
7.132200E-02 |
| Stage2-vs-Stage4 |
6.891600E-01 |
| Stage3-vs-Stage4 |
4.968600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.81649999989142E-07 |
| Normal-vs-AfricanAmerican |
6.19840000000149E-05 |
| Normal-vs-Asian |
1.119160E-03 |
| Caucasian-vs-AfricanAmerican |
6.713800E-01 |
| Caucasian-vs-Asian |
5.352200E-01 |
| AfricanAmerican-vs-Asian |
3.945000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.60429996748968E-09 |
| Normal-vs-Female |
2.880200E-02 |
| Male-vs-Female |
1.377700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.358870E-04 |
| Normal-vs-Extreme_Weight |
8.4169999969852E-08 |
| Normal-vs-Obese |
2.595500E-03 |
| Normal-vs-Extreme_Obese |
4.24640000000753E-05 |
| Normal_Weight-vs-Extreme_Weight |
5.429800E-01 |
| Normal_Weight-vs-Obese |
1.776990E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.538200E-01 |
| Extreme_Weight-vs-Obese |
2.140400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.539400E-01 |
| Obese-vs-Extreme_Obese |
9.548000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.713600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.208220E-04 |
| Normal-vs-Age(61-80Yrs) |
1.65360000137227E-08 |
| Normal-vs-Age(81-100Yrs) |
2.36599999999809E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.726200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.332800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.069000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.856200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.601240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.385200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.66250000117097E-08 |
| Normal-VS-Type2 PRCC |
2.12839999998993E-05 |
| Normal-VS-KIRP CIMP |
4.168600E-01 |
| Normal-VS-Unclassified PRCC |
4.539200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.639400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.047200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.327800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.350400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.835200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.699800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.04910000078939E-08 |
| Normal-vs-N1 |
7.598400E-01 |
| Normal-vs-N2 |
2.874200E-01 |
| N0-vs-N1 |
3.835900E-03 |
| N0-vs-N2 |
1.237800E-01 |
| N1-vs-N2 |
5.783200E-01 |
|
|
